Pharmaceutical drugs in the treatment of STEMI

Show simple item record Ker, James A. 2016-09-02T08:00:19Z 2016-09-02T08:00:19Z 2016-08
dc.description.abstract Our concept of ST-segment Elevated Myocardial Infarction (STEMI) refers to when coronary blood supply decreases abruptly after a thrombotic occlusion. The underlying mechanism leading to the thrombotic event is an unstable atherosclerotic plaque which ruptured (or cracked or eroded) exposing the content of the plaque to the blood initiating thrombogenesis. en_ZA
dc.description.department Internal Medicine en_ZA
dc.description.librarian am2016 en_ZA
dc.description.uri en_ZA
dc.identifier.citation Ker, J 2016, 'Pharmaceutical drugs in the treatment of STEMI', The Specialist Forum, vol. 16, no. 7, pp. 20. en_ZA
dc.identifier.issn 2218-8282
dc.language.iso en en_ZA
dc.publisher New Media Publishing en_ZA
dc.rights © The Specialist Forum en_ZA
dc.subject Thrombotic occlusion en_ZA
dc.subject Unstable atherosclerotic plaque en_ZA
dc.subject Coronary blood supply en_ZA
dc.subject ST-segment Elevated Myocardial Infarction (STEMI) en_ZA
dc.title Pharmaceutical drugs in the treatment of STEMI en_ZA
dc.type Article en_ZA

Files in this item

This item appears in the following Collection(s)

Show simple item record